| Entry |
|
|---|
| Name |
Foscarbidopa (USAN/INN) |
|---|
| Formula |
C10H15N2O7P
|
|---|
| Exact mass |
306.0617
|
|---|
| Mol weight |
306.21
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG01967 Antiparkinson agent
|
|---|
| Remark |
| Product (mixture): | D12494<JP/US> |
|
|---|
| Efficacy |
Antiparkinsonian |
|---|
| Comment |
Treatment of Parkinson's disease
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01967 Antiparkinson agent
DG03153 Foscarbidopa
D12057 Foscarbidopa
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01967 Antiparkinson agent
DG03153 Foscarbidopa
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 20
1 C8y C 16.8329 -16.1384
2 C8y C 16.8329 -17.5417
3 C8x C 18.0258 -18.2434
4 C8x C 19.2887 -17.5417
5 C8y C 19.2887 -16.1384
6 C8x C 18.0258 -15.4367
7 O1a O 15.6401 -15.4367
8 O2b O 15.6401 -18.2434
9 C1b C 20.4816 -15.4367
10 C1d C 21.6744 -16.1384
11 C6a C 22.8672 -15.4367
12 O6a O 24.0601 -16.1384
13 O6a O 22.8672 -14.0334
14 N1b N 22.3761 -17.3312
15 C1a C 20.6921 -17.1207
16 N1a N 23.7794 -17.3312
17 P1b P 14.3771 -17.5417
18 O1c O 13.1843 -18.3136
19 O1c O 14.3771 -16.1384
20 O1c O 13.1843 -16.8401
BOND 20
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 1 7 1
8 2 8 1
9 5 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 11 13 2
14 10 14 1 #Up
15 10 15 1 #Down
16 14 16 1
17 8 17 1
18 17 18 1
19 17 19 1
20 17 20 2
|
|---|
